Global saliva collection and diagnostics market expected to reach USD 1235.11 million by 2032

From GlobeNewswire: 2025-06-30 08:30:00

The global Saliva Collection and Diagnostics Market was valued at USD 819.29 million in 2023, expected to reach USD 1235.11 million by 2032, with a CAGR of 4.70%. The U.S. market was estimated at USD 273.98 million in 2023, set to reach USD 404.96 million by 2032. Saliva diagnostics are driving market growth.

Saliva diagnostics offer cheaper, painless, and safer testing compared to traditional methods. The trend is shifting towards early disease diagnosis, especially in infectious diseases, hormonal disorders, and cancer. Increasing consumer focus on personal health and wellness is also driving the market expansion, with key players introducing at-home collection kits.

Major players in the market include Thermo Fisher Scientific, Neogen Corporation, Abbott Laboratories, Sarstedt AG, and more. The market is segmented by site of collection, application, and end-user. North America leads in demand, with the U.S. holding the largest share, while Asia Pacific is the fastest-growing region due to rising awareness and medical expenditure.

Recent developments include ZRT Laboratory’s new Steroid LC-MS Hormone Profile 7, Salimetrics’ Saliva Collection Aid 2.0, and DNA Genotek’s OMNIgene ORAL OM-120. SNS Insider is a leading market research agency providing clients with accurate market data and insights to make informed decisions. Visit their website for more information on the Saliva Collection and Diagnostics Market report.



Read more at GlobeNewswire: Saliva Collection and Diagnostics Market to Hit USD 1235.11